About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 581281, 7 pages
Research Article

Preparation of 99mTc-Clomiphene Citrate as a Novel Agent for Breast Cancer Imaging

1Labeled Compound Department, Hot Lab Center, Egyptian Atomic Energy Authority, Cairo 11371, Egypt
2Faculty of Pharmacy, Cairo University, Cairo, Egypt

Received 29 July 2012; Accepted 20 September 2012

Academic Editors: D. E. Bassi and M. Emoto

Copyright © 2012 Ismail Taha Ibrahim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Khalkhali, J. A. Cutrone, I. G. Mena et al., “Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma,” Radiology, vol. 196, no. 2, pp. 421–426, 1995. View at Scopus
  2. H. Palmedo, F. Grünwald, H. Bender et al., “Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging,” European Journal of Nuclear Medicine, vol. 23, no. 8, pp. 940–946, 1996. View at Scopus
  3. F. J. T. Wackers, D. S. Berman, J. Maddahi et al., “Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging,” Journal of Nuclear Medicine, vol. 30, no. 3, pp. 301–311, 1989. View at Scopus
  4. S. S. Sun, J. F. Hsieh, S. C. Tsai, Y. J. Ho, J. K. Lee, and C. H. Kao, “Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results,” Cancer Letters, vol. 153, no. 1-2, pp. 95–100, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Filipits, R. W. Suchomel, G. Dekan et al., “MRP and MDR1 gene expression in primary breast carcinomas,” Clinical Cancer Research, vol. 2, no. 7, pp. 1231–1237, 1996. View at Scopus
  6. S. Del Vecchio, A. Ciarmiello, M. I. Potena et al., “In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients,” European Journal of Nuclear Medicine, vol. 24, no. 2, pp. 150–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Barbarics, J. F. Kronauge, A. Davison, and A. G. Jones, “Uptake of cationic technetium complexes in cultured human carcinoma cells and human xenografts,” Nuclear Medicine and Biology, vol. 25, no. 7, pp. 667–673, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Butt, C. E. Caldon, C. M. McNeil, A. Swarbrick, E. A. Musgrove, and R. L. Sutherland, “Cell cycle machinery: links with genesis and treatment of breast cancer,” Advances in Experimental Medicine and Biology, vol. 630, pp. 189–205, 2008. View at Scopus
  9. J. Cuzick, D. Y. Wang, and R. D. Bulbrook, “The prevention of breast cancer,” The Lancet, vol. 1, no. 8472, pp. 83–86, 1986. View at Scopus
  10. W. Shelly, M. W. Draper, V. Krishnan, M. Wong, and R. B. Jaffe, “Selective estrogen receptor modulators: an update on recent clinical findings,” Obstetrical and Gynecological Survey, vol. 63, no. 3, pp. 163–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Gazit, T. Livshitz, and J. Shani, “Fluoro-clomiphene and its synthetic precursors: synthesis and receptor binding,” Steroids, vol. 48, no. 1-2, pp. 73–84, 1987. View at Scopus
  12. L. C. Murphy and R. L. Sutherland, “Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 2, pp. 373–379, 1983. View at Scopus
  13. J. F. Richards and D. R. Griffith, “Effect of cis and trans clomiphene on mammary gland development in the rat,” Fertility and Sterility, vol. 25, no. 1, pp. 74–78, 1974. View at Scopus
  14. E. Hecker, I. Vegh, and C. M. Levy, “Clinical trial of clomiphene in advanced breast cancer,” European Journal of Cancer and Clinical Oncology, vol. 10, no. 11, pp. 747–749, 1974. View at Scopus
  15. R. J. Baumann, T. L. Bush, D. E. Cross-Doersen et al., “Clomiphene analogs with activity in vitro and in vivo against human breast cancer cells,” Biochemical Pharmacology, vol. 55, no. 6, pp. 841–851, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. O'Brian, R. M. Liskamp, D. H. Solomon, and I. B. Weinstein, “Triphenylethylenes: a new class of protein kinase C inhibitors,” Journal of the National Cancer Institute, vol. 76, no. 6, pp. 1243–1246, 1986. View at Scopus
  17. T. C. Chambers, E. M. McAvoy, J. W. Jacobs, and G. Eilon, “Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells,” The Journal of Biological Chemistry, vol. 265, no. 13, pp. 7679–7686, 1990. View at Scopus
  18. S. E. Bates, J. S. Lee, B. Dickstein, M. Spolyar, and A. T. Fojo, “Differential modulation of P-glycoprotein transport by protein kinase inhibition,” Biochemistry, vol. 32, no. 35, pp. 9156–9164, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Abu-Zeid, H. Hori, H. Nagasawa, Y. Uto, and S. Inayama, “Studies of methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) 2: effect on certain antioxidant enzyme systems in mice bearing Ehrlich ascites carcinoma,” Biological and Pharmaceutical Bulletin, vol. 23, no. 2, pp. 195–198, 2000. View at Scopus
  20. C. Celerier, N. Robert, J. Bertrand-Barat, and D. Ducassou, “Nuclear medicine functional imaging,” Médecine Nucléaire Imagerie Fonctionnelle et Métabolique, vol. 21, p. 373, 1997.
  21. F. E. I. Liu, H. E. Youfeng, and Z. Luo, Technical Reports Series no. 426, IAEA, Vienna, Austria, pp. 37–52, 2004.
  22. R. Lettré, N. Paweletz, D. Werner, and C. Granzow, “Sublines of the ehrlich-lettré mouse ascites tumour a new tool for experimental cell research,” Die Naturwissenschaften, vol. 59, no. 2, pp. 59–63, 1972. View at Publisher · View at Google Scholar · View at Scopus
  23. K. R. Sheeja, G. Kuttan, and R. Kuttan, “Cytotoxic and antitumour activity of Berberin,” Amala Research Bulletin, vol. 17, pp. 73–76, 1997.
  24. T. J. Lampidis, Y. F. Shi, C. L. Calderon, D. Kolonias, H. Tapiero, and N. Savaraj, “Accumulation of simple organic cations correlates with differential cytotoxicity in multidrug-resistant and -sensitive human and rodent cells,” Leukemia, vol. 11, no. 7, pp. 1156–1159, 1997. View at Scopus